Mediating effects of maternal blood lipids and glucose on the relationship between pre-pregnancy body mass index and newborn birth weight in women with gestational diabetes mellitus Authors: Hanbing Li, Zhixuan Xiang, Hui Li, Chenxi Xie, Zeng Li, Yingni Liang, Lingling Gao, Zhongyu Li Published: 2025 ABSTRACT AbstractBackgroundThe effect of maternal blood lipids and glucose on the relationship between pre-pregnancy body mass index (BMI) and newborn birthweight (NBW) in pregnant women with gestational diabetes mellitus (GDM) remains unclear. This study aimed to examine whether maternal blood lipids and glucose mediate the relationship between pre-pregnancy BMI and NBW in pregnant women with GDM.MethodsA retrospective study was conducted on 1257 women with GDM who gave birth at the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, between November 2017 and July 2021. Maternal blood lipids were measured at the first prenatal care (6–13 weeks of gestation). Glucoses, including mid-pregnancy fasting plasma glucose (FPG) and post-load glucose, were measured at 24–28 gestational weeks using an oral glucose tolerance test (OGTT). Multivariable linear regression was used to evaluate the significance of assumed paths. According to the results of multivariable linear regression, significant lipids and glucose were included in a multiple mediation analysis as mediators. Sensitivity analysis was performed to verify the robustness of the results.ResultsEarly-pregnancy high-density lipoprotein cholesterol (HDL-C) and mid-pregnancy FPG were associated with pre-pregnancy BMI and NBW. Early-pregnancy HDL-C was associated with mid-pregnancy FPG. The multiple mediation analysis revealed that pre-pregnancy BMI not only had a direct effect on NBW (effect = 23.592, 95% CI [14.366, 32.306]) but also had an indirect effect (effect = 5.602, 95%CI [2.812, 8.648]) on NBW through three paths: the independent mediating role of early-pregnancy HDL-C (effect = 1.649, 95% CI [0.103, 3.472]); the independent mediating role of mid-pregnancy FPG (effect = 3.739, 95% CI [1.653, 6.164]); and the multiple chain-mediating role of early-pregnancy HDL-C and mid-pregnancy FPG (effect = 0.214, 95% CI [0.054, 0.508]). The mediated proportions of the three paths were 5.65%, 12.81%, and 0.73%.ConclusionsMaternal early- pregnancy HDL-C and mid-pregnancy FPG partially mediate the association between pre-pregnancy BMI and NBW in pregnant women with GDM.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12884-025-08264-x.Keywords: Birth weight, Gestational diabetes mellitus, Oral glucose tolerance test, High-density lipoprotein cholesterol, Mediation analysis Background Gestational diabetes mellitus (GDM) refers to abnormal glucose tolerance that first becomes apparent or recognized during pregnancy [1]. GDM impairs the health of several million women and their fetuses worldwide [2]. Newborn birthweight (NBW) refers to newborn birthweight within one hour after delivery and is one of the most direct indicators of newborn health. NBW is also the most common health outcome studied to determine if the maternal intrauterine environment influences the development of the fetus [3]. Many studies have indicated that infants whose mothers have GDM have greater odds of having abnormal birth weight. GDM increases the risks of macrosomia and large for gestational age (LGA) [4, 5]. Moreover, when expectant mothers with GDM undergo rigorous dietary, physical activity, or insulin interventions, it may exacerbate the severity of low birth weight (LBW) and small for gestational age (SGA) [6]. Increased NBW is associated with dystocia, postpartum hemorrhage, obstetric anal sphincter injury, and birth fractures [7]. Reduced NBW is related to neonatal mortality [8]. Children and adolescents with abnormal NBWs are at increased risk for hypertension, cardiovascular disease, etc [9, 10]. Maternal nutritional status ensures a continuous supply of nutrients to developing fetuses. Pre-pregnancy body mass index (BMI), which is an indicator of maternal nutritional status, is a strong predictor of NBW [11, 12]. Many studies have shown that high pre-pregnancy BMI increases the risks of macrosomia and LGA [13–16]. Moreover, being underweight increases the risks of LBW and SGA [14, 15]. However, most pregnant women in China do not search for medical services until pregnancy is detected. It is not easy for healthcare professionals to change pregnant women’s pre-pregnancy BMI. Therefore, it is essential to identify the factors that mediate the relationship between pre-pregnancy BMI and NBW, which could help healthcare professionals clarify how pre-pregnancy BMI affects NBW and utilize mediating factors to adjust and control NBW during pregnancy. Maternal blood lipids and glucose levels are also associated with NBW. Fetal growth relies on glucose, transported from the mother through the placenta [17]. Thus, maternal blood glucose affects NBW directly. Abnormal fasting plasma glucose (FPG) and post-load glucose concentrations after oral glucose tolerance test (OGTT) are risk factors for higher NBW [18, 19]. High maternal triglyceride (TG) levels and low High-density lipoprotein cholesterol (HDL-C) levels increase the risk of LGA and macrosomia, and decrease the risk of SGA [20–22]. HDL-C can influence glucose metabolism through multiple mechanisms [23]. Moreover, HDL-C is associated with placental size [24] and epigenetic aging [25], both of which are related to NBW. Pre-pregnancy BMI is associated with FPG, total cholesterol (TC), low-density-lipoprotein cholesterol (LDL-C), and HDL-C [26]. Furthermore, TG and HDL-C are associated with insulin resistance [27]. Theoretically, maternal blood lipids and glucose may mediate the relationship between pre-pregnancy BMI and NBW. Some studies have demonstrated the mediating role of maternal blood lipids or glucose in the association of maternal pre-pregnancy BMI with NBW [16, 28–31]. These studies were conducted in normal pregnant women or nondiabetic pregnant women. Pregnant women with GDM have different glucose and lipid metabolisms from pregnant women without GDM [32]. Compared with normal pregnant women, they have higher blood glucose and lower HDL-C [33, 34]. However, few studies examine the mediating effects of blood lipids and glucose on the relationship between pre-pregnancy BMI and NBW among pregnant women with GDM. Additionally, although lipid metabolism plays a crucial role in glucose metabolism [23, 35], few studies have explored the multiple mediating effects of maternal lipids and glucose on the relationship between pre-pregnancy BMI and NBW. Fortunately, blood lipids and glucose could be routinely assessed in antenatal care in mainland China. Maternal blood lipids are typically tested during the first antenatal care visit, which usually occurs between 6 and 13 weeks’ gestation. The 75-g OGTT is performed between 24 and 28 weeks’ gestation [36]. Moreover, pregnant women can regulate their blood lipids and glucose through medical interventions. These provide an opportunity for healthcare professionals to intervene promptly and maintain normal NBW. Therefore, it is necessary to explore maternal lipid levels and glucose levels, and whether they act as mediators in the association between pre-pregnancy BMI and NBW in pregnant women with GDM. Thus, our study aimed to examine whether maternal blood lipids and glucose mediate the relationship between pre-pregnancy BMI and NBW in pregnant women with GDM. Methods Ethical approval This study was approved by the Ethics Committee of Sun Yat-sen University School of Nursing (Grant No. L2022SYSU-HL-016). The requirement for informed consent was waived by the committee due to the retrospective nature of the study. We ensured all patient data were de-identified and maintained confidentiality throughout the research process in compliance with the ethical standards of the Declaration of Helsinki. Design and participants A retrospective study was conducted. The data were extracted from 1257 pregnant women with GDM who gave birth at the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, from November 2017 to July 2021. The inclusion criterion was pregnant women with GDM. Pregnant women were diagnosed with GDM via 75 g OGTT at 24–28 weeks of gestation based on the criteria of the International Association of Diabetes and Pregnancy Study Groups (IADPSG). The IADPSG criteria defined GDM as FPG ≥ 5.1 mmol/L, or 1-h glucose ≥ 10.0 mmol/L, or 2-h glucose ≥ 8.5 mmol/L [33]. The exclusion criteria were: (i) multiple pregnancies; (ii) pre-gestational diabetes; (iii) other serious diseases such as heart disease, liver disease, and kidney disease; (iv) abortion or induced labor or intrauterine fetal death; (v) preterm birth; and (vi) missing data. Variables and measurements The outcome variable was the NBW (g), which refers to the weight of the newborn measured in the delivery room at birth. We obtained this information from medical records. The independent variable of pre-pregnancy BMI was calculated by dividing the self-reported pre-pregnancy weight in kilograms by the height in meters squared (Kg/m²). The height was measured during the first prenatal care visit, which typically occurs between 6 and 13 weeks of gestation. The height was measured using standard procedures in 0.1 cm increments on a stadiometer, while pregnant women were barefoot. Mediators included maternal blood lipids in early pregnancy and blood glucose levels tested in the OGTT in 24–28 gestational weeks. The maternal blood lipid concentrations (TG, TC, HDL-C, LDL-C) were measured by enzymatic methods at the first prenatal care visit, which requires pregnant women to fast. Candidate covariates included maternal age, education level, parity, assisted reproductive technology (ART), weight gain, and fetal sex. At registration for pregnancy, sociodemographic and obstetric characteristics, including maternal age, education level, parity, and use of assisted reproductive technology (ART), were recorded. Weight gain was calculated by subtracting the weight measured when pregnant women were admitted to the hospital for delivery from the pre-pregnancy weight. Weight was measured using standard procedures in units of 0.1 kg on a digital scale, with participants wearing light clothing. Pre-pregnancy weight was self-reported at the first prenatal care visit. Fetal sex was recorded after birth. We also obtained these data from the women’s medical records. Unfortunately, the present study did not include diet, exercise, and insulin therapy as covariates because the women’s medical records did not contain such information. The selection of candidate covariates was based on a combination of the existing biological knowledge, reviewed literature, and data availability. Data analysis This study employed descriptive statistics to present sociodemographic and obstetric characteristics, as well as the study variables. The data were presented as the means (SDs), medians (IQRs), or percentages, as appropriate. We hypothesized that blood lipid concentrations and OGTT glucose might mediate the association between pre-pregnancy BMI and NBW (Fig. 1). The mediation effect existed on the premise that the associations were significant for all paths. Therefore, we used multivariable linear regression to evaluate the significance of all paths, adjusted for potential confounders, including maternal age, parity, ART, fetal sex, and weight gain. The covariates were selected among candidate covariates by conducting an independent-sample t-test and simple linear regression between NBW and candidate covariates. All the variables with p < 0.25 in the above tests were input into a multivariable linear regression model as covariates [37]. According to the results of the multivariable linear regression, we included early- pregnancy HDL-C in the mediation analysis as Mediator 1 (M1) and included mid-pregnancy FPG as Mediator 2 (M2). Although one-hour post-load glucose is associated with NBW, it is not associated with early- pregnancy HDL-C. Thus, we didn’t include one-hour post-load glucose as a mediator. To accurately calculate the total, direct, and indirect effects, we used the “Lavaan” package in R 4.1.2 (R Foundation for Statistical Computing, Vienna, Austria) with 10,000 simulations by bootstrap. A path figure was drawn to visualize the relationship among pre-pregnancy BMI, NBW, mid-pregnancy FPG, and early- pregnancy HDL-C. We employed the χ2/degrees of freedom (df) ratio (χ2/df < 3), root mean square error of approximation (RMSEA < 0.08), comparative fit index (CFI > 0.90), and Tucker Lewis index (TLI > 0.90) to assess the model fit. Additionally, there may be unmeasured confounding factors (e.g., diet, exercise, and insulin therapy); thus, the sensitivity analysis using the method of inverse probability weighting was conducted to evaluate the robustness of the results. Mediation model for pre-pregnancy BMI, NBW, blood glucose and lipids. The illustration of the total effect (path D), direct effect (path D’), and indirect effect (path A, path A’, path B, path B’, path C) on the relationship of X with Y. Abbreviations: BMI, body mass index; OGTT, oral glucose tolerance test; NBW, newborn birth weight Results Baseline characteristics of the participants Figure 2 shows the participants’ selection process. A total of 1257 pregnant women with GDM were included in this study (Fig. 2). Table 1 presents the sociodemographic and obstetric characteristics of pregnant women with GDM. The mean of NBW is 3213.64 ± 392.44 g. Among 1257 newborns, 673 (53.5%) were boys, and 584 (46.5%) were girls. The prevalence of LBW was 2.4% (n = 30), while the prevalence of macrosomia was 2.8% (n = 35). Enrollment of pregnant women with gestational diabetes mellitus Table 1The sociodemographic and obstetric characteristics of the study population (N = 1257)CharacteristicsValuesAge, y, n (%) < 35840 (66.8) ≥ 35417 (33.2)Education, n (%) High school or below126 (10.0) College or above1131 (90.0)Parity, n (%) Parity zero523 (41.6) Multipara734 (58.4)ART, n (%) Yes55 (4.4) No1202 (95.6)Fetal sex, n (%) Male673 (53.5) Female584 (46.5)Weight gain, Kg10.50 (8.00,13.50)Pre-pregnancy BMI, Kg/m2, x ± s21.71 ± 3.06FPG, mmol/L, x ± s4.51 ± 0.52One-hour post-load glucose, mmol/L, x ± s9.95 ± 1.38Two-hour post-load glucose, mmol/L, x ± s8.94 ± 1.21TC, mmol/L, x ± s4.71 ± 0.84TG, mmol/L, x ± s1.47 ± 0.68HDL-C, mmol/L, x ± s1.58 ± 0.32LDL-C, mmol/L, M (P25, P75)2.59 (2.17,3.03)NBW, g, x ± s3213.64 ± 392.44Abbreviations ART assisted reproductive technology, BMI body mass index, FPG fasting plasma glucose, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, NBW newborn birthweight, TC total cholesterol, TG triglyceride The sociodemographic and obstetric characteristics of the study population (N = 1257) Abbreviations ART assisted reproductive technology, BMI body mass index, FPG fasting plasma glucose, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, NBW newborn birthweight, TC total cholesterol, TG triglyceride Evaluation of the significance of all paths The results of the multivariable linear regression models are shown in Table 2. As shown in Table 3, the variables with p < 0.25 including maternal age, parity, ART, fetal sex, and weight gain were treated as covariates in the multivariable linear regression models for evaluating the paths A, B, B’, A’, C, and D. Pre-pregnancy BMI was associated with NBW (path D), early- pregnancy HDL-C (path A), and mid-pregnancy FPG (path B). In addition, mid-pregnancy FPG was associated with early- pregnancy HDL-C (path C). After adjusting for one another (TG, TC, HDL-C, and LDL-C) and other potential confounders, early- pregnancy HDL-C showed a significant association with NBW (path A’). Adjusted for one-hour post-load, two-hour glucose, and other confounders, mid-pregnancy FPG was significantly associated with NBW (path B’). Additionally, one-hour post-load glucose was related to NBW, but not to any of the blood lipids (see Supplementary Table 1). Table 2The significant results of multivariable linear regression for evaluating all pathsVariablesNBWHDL-CFPGModel 1Model 2Model 3Model 4Model 5Model 6Std. βSEStd. βSEStd. βSEStd. βSEStd. βSEStd. βSEConstant94.2883.49139.060.080.130.09Age ≥ 35 years−0.01724.630.01525.070.00524.860.102 **0.02−0.0040.030.0480.03Parity zero−0.087 **23.34−0.097 **23.84−0.094 **23.580.0080.02−0.0440.03−0.065 *0.03ART0.03252.190.02953.410.02752.92−0.0030.040.057 *0.070.061 *0.07Fetal sex0.129 ***21.080.136 ***21.480.132 ***21.30< 0.0010.020.0120.030.0200.03Weight gain0.237 ***2.290.193 ***2.280.181 ***2.260.035< 0.010.069 **< 0.010.006< 0.01Pre-pregnancy BMI (Kg/m2)0.227 ***3.62−0.223 ***< 0.010.307 ***0.01HDL-C (mmol/L)−0.102 **40.87−0.134 ***0.05TC (mmol/L)0.01915.88TG (mmol/L)0.05218.24LDL-C (mmol/L)−0.0222.09FPG (mmol/L)0.174 ***21.18One-hour post-load glucose (mmol/L)−0.060 *8.20Two-hour post-load glucose (mmol/L)0.0419.21Models 1–6 examined paths D, A’, B’, A, B, and C, respectivelyAbbreviations ART assisted reproductive technology, BMI body mass index, FPG fasting plasma glucose, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, NBW newborn birthweight, Std. standardized, TC total cholesterol, TG triglyceride* p < 0.05; ** p < 0.01; *** p < 0.001 The significant results of multivariable linear regression for evaluating all paths Models 1–6 examined paths D, A’, B’, A, B, and C, respectively Abbreviations ART assisted reproductive technology, BMI body mass index, FPG fasting plasma glucose, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, NBW newborn birthweight, Std. standardized, TC total cholesterol, TG triglyceride * p < 0.05; ** p < 0.01; *** p < 0.001 Table 3Univariate analysis of sociodemographic and obstetric characteristics and NBW (N = 1257)CharacteristicsNBWx ± stPAge, y−1.446 a0.149 < 353202.33 ± 390.93 ≥ 353236.43 ± 394.96Education−0.395 a0.693 High school or below3200.56 ± 386.72 College or above3215.10 ± 393.21Parity3.131 a0.002 Parity zero3172.73 ± 395.07 Multipara3242.79 ± 388.20ART−1.515 a0.130 Yes3292.00 ± 412.09 No3210.06 ± 391.32Fetal sex−4.755 a< 0.001 Male3261.95 ± 405.48 Female3157.98 ± 369.44Weight gain, g3213.64 ± 392.446.101 b< 0.001Abbreviations ART assisted reproductive technology, NBW newborn birthweighta t testb liner regression Univariate analysis of sociodemographic and obstetric characteristics and NBW (N = 1257) Abbreviations ART assisted reproductive technology, NBW newborn birthweight a t test b liner regression Mediation analysis The data fit of the model was good (χ2/df = 2.775, RMSEA = 0.038, CFI = 0.984, TLI = 0.966). Moreover, the results of the sensitivity analysis using the method of inverse probability weighting are presented in Table 4, which are similar to those of the original mediation analysis, indicating the robustness of the mediation model. Table 4; Fig. 3 show the results of the mediation analysis. The mediation analysis suggested that the total effect of pre-pregnancy BMI on NBW was 29.194 (95% CI, 20.367–37.582), comprising a direct effect of 23.592 (95% CI, 14.366–32.306) and a total indirect effect of 5.602 (95% CI, 2.812–8.648). The total indirect effect consisted of three parts: (1) pre-pregnancy BMI → early- pregnancy HDL-C → NBW: 1.649 (95% CI, 0.103–3.472); (2) pre-pregnancy BMI → mid-pregnancy FPG → NBW: 3.739 (95% CI, 1.653–6.164); and (3) pre-pregnancy BMI → early- pregnancy early- pregnancy HDL-C → mid-pregnancy FPG → NBW: 0.214 (95% CI, 0.054–0.508). Table 4Results of mediation effects between original and inverse probability weighting modelsOriginal effect size (95% CI)Original mediated proportion (%)IPW-effect size(95% CI)IPW-mediated proportion (%)Total effect28.948 [20.554, 37.694] ***/30.334 [21.222, 38.653] ***/Direct effect23.586 [14.817, 32.701] ***81.4724.434 [15.098, 33.221] ***80.55Total indirect effect5.363 [2.660, 8.189] ***18.535.900 [2.979, 9.079] ***19.45Indirect effect a1.574 [0.103, 3.222] *5.441.636 [0.037, 3.621] *5.39Indirect effect b3.595 [1.521, 5.884] ***12.424.030 [1.870, 6.640] ***13.29Indirect effect c0.193 [0.069, 0.445] *0.670.234 [0.065, 0.572] **0.77Abbreviations CI confidence interval, IPW inverse probability weightinga pre-pregnancy body mass index → high-density lipoprotein cholesterol → newborn birthweightb pre-pregnancy body mass index → oral glucose tolerance test-fasting plasma glucose → newborn birthweightc pre-pregnancy body mass index → high-density lipoprotein cholesterol → oral glucose tolerance test-fasting plasma glucose → newborn birthweight* p < 0.05; ** p < 0.01; *** p < 0.001 Results of mediation effects between original and inverse probability weighting models Abbreviations CI confidence interval, IPW inverse probability weighting a pre-pregnancy body mass index → high-density lipoprotein cholesterol → newborn birthweight b pre-pregnancy body mass index → oral glucose tolerance test-fasting plasma glucose → newborn birthweight c pre-pregnancy body mass index → high-density lipoprotein cholesterol → oral glucose tolerance test-fasting plasma glucose → newborn birthweight * p < 0.05; ** p < 0.01; *** p < 0.001 Mediation model for pre-pregnancy BMI, NBW, mid-pregnancy FPG, and early- pregnancy HDL-C. Abbreviations: BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; FPG, fasting plasma glucose; NBW, newborn birth weight Discussion The present study found that maternal pre-pregnancy BMI was positively related to NBW in pregnant women with GDM. It revealed three significant pathways by which pre-pregnancy BMI affected NBW in pregnant women with GDM, including the independent mediating roles of mid-pregnancy FPG and early- pregnancy HDL-C, as well as their multiple chain-mediating roles. This study showed that pre-pregnancy BMI had a direct effect on NBW in pregnant women with GDM, which was consistent with previous studies that the risks of LGA and macrosomia were significantly increased with the increasing pre-pregnancy BMI [13, 14]; and the risks of LBW and SGA increased considerably in underweight pregnant women [13–15]. It may be due to that the umbilical cord blood metabolome is influenced by maternal characteristics, such as pre-pregnancy BMI, and the metabolome from the umbilical cord blood has been correlated with NBW [38, 39]. Moreover, pre-pregnancy BMI reflects the nutritional status of the mother in general, and fetal development depends on the transport of nutrients from the mother [17]. Therefore, pre-pregnancy BMI was positively associated with NBW. The present study found that both pre-pregnancy BMI and mid-pregnancy FPG were associated with NBW, and mid-pregnancy FPG was a partial mediator of the relationship between pre-pregnancy BMI and NBW in pregnant women with GDM. These results were consistent with the previous studies [21, 28, 41]. Previous studies have demonstrated that pregnant women with higher BMI have higher FPG [26, 40]. A meta-analysis reported a positive linear association between FPG and NBW [19], and another study showed that GDM with abnormal FPG was associated with higher NBW centiles [18]. Furthermore, it has been indicated that blood glucose levels obtained through an OGTT are a partial mediator between pre-pregnancy BMI and NBW [16]. Another study also showed that FPG was the most potent mediator in the association between pre-pregnancy BMI and NBW [31]. It may be because fetal growth depends on the transport of nutrients from the mother to the fetus through the placenta. Glucose is the primary substrate for fetal growth [17]. Maternal BMI was associated with adipokines, such as leptin and adiponectin, which play a role in regulating glucose metabolism [41]. High levels of leptin and low levels of adiponectin are associated with elevated blood glucose [42, 43]. However, in the present study, BMI was measured pre-pregnancy, while FPG was measured during the 24–28-week gestation period. Thus, pre-pregnancy BMI was positively associated with NBW, with FPG partially mediating this relationship. This study also demonstrated that both pre-pregnancy BMI and early- pregnancy HDL-C were related to NBW, and early- pregnancy HDL-C partially mediated the relationship between pre-pregnancy BMI and NBW. These results were consistent with the previous studies. Several studies have suggested that women with higher BMI have lower HDL-C levels [26, 44]. A meta-analysis comprising 46 publications revealed that low HDL-C levels were associated with increased NBW [22]. Prior studies have suggested that pre-pregnancy BMI is associated with betatrophin, and betatrophin is negatively correlated with HDL-C [45], thus, pre-pregnancy BMI is related to HDL-C. It has been shown that low HDL-C is associated with heavy placental weight and epigenetic aging acceleration [24, 25], and characteristics and functions of the placenta directly affect NBW; therefore, HDL-C was associated with NBW. In the present study, BMI was measured pre-pregnancy, while HDL-C was measured during the 6 and 13 weeks of gestation, which may contribute to the partial mediation of the relationship between pre-pregnancy BMI and NBW. The present study also found that early-pregnancy HDL-C was associated with mid-pregnancy FPG. There was a partial mediating role of early-pregnancy HDL-C and mid-pregnancy FPG in the relationship between pre-pregnancy BMI and NBW. The negative correlation between early-pregnancy HDL-C and mid-pregnancy FPG may be due to the HDL-C functions. The metabolism of pregnant women with GDM may change from early pregnancy. Insulin sensitivity may decrease from early pregnancy and is reduced further in mid-late pregnancy [46, 47]. Early-pregnancy HDL may influence glucose metabolism via enhancing insulin secretion from pancreatic beta cells (achieved by facilitating cholesterol efflux from β-cell and mitigating inflammation), promoting insulin independent glucose uptake in skeletal muscle (achieved by activation of the AMP-activated protein kinase pathway), and improving insulin sensitivity (achieved by revising cholesterol transport and anti-inflammatory effects in peripheral tissues) [35]. Therefore, women with low early-pregnancy HDL-C have low insulin sensitivity and their insulin sensitivity will further significantly decrease in mid-late pregnancy, which may be an explanation for the relationship between early-pregnancy HDL-C and mid-pregnancy FPG. Several studies have also demonstrated that early-pregnancy HDL-C are significant predictors of GDM [48, 49]. Low early-pregnancy HDL-C was associated with a high risk of GDM [50]. However, few studies provided direct evidence proving the relationship between early-pregnancy HDL-C and mid-pregnancy FPG. The findings of the present study have significant clinical implications. The findings of the present study suggested that early-pregnancy HDL-C and mid-pregnancy FPG could be used as biomarkers for the NBW, especially early-pregnancy HDL-C, because early prediction as early as the first trimester would help healthcare professionals to identify, diagnose, and eradicate the condition. As HDL-C and FPG are easy and cheap to measure, it is feasible for healthcare professionals to monitor early-pregnancy HDL-C and mid-pregnancy FPG to identify pregnant women at high risk for abnormal NBW and intervene promptly. However, the present study indicated that early- pregnancy HDL-C and mid-pregnancy FPG are only partial mediators between pre-pregnancy BMI and NBW; thus, the independent contributions of early- pregnancy HDL-C and mid-pregnancy FPG may not be sufficient to guide intervention strategies. This study has some limitations. Firstly, the reliance on self-reported pre-pregnancy BMI may introduce potential bias. Secondly, the retrospective design limits the ability to infer causality. Consider discussing the potential for a prospective design in future research to enable stronger causal inferences. Thirdly, this study did not account for additional confounders, such as physical activity, diet, and socioeconomic status, which may affect the robustness of the results. To address this issue, we performed the sensitivity analysis using the method of inverse probability weighting to account for potential selection bias and unmeasured confounders by constructing propensity score models to reweight the sample. The results of IPW closely matched our original findings, indicating the robustness of the results. But it is better to include these confounders in the analysis to provide a more comprehensive understanding of the factors influencing NBW in future studies. Conclusion This study suggested that pre-pregnancy BMI is associated with NBW and mediated via early- pregnancy HDL-C and mid-pregnancy FPG in pregnant women with GDM. Furthermore, early- pregnancy HDL-C and mid-pregnancy FPG as partial mediators are worthy of attention. To control NBW, early- pregnancy HDL-C may need to be monitored in the future, except for blood glucose. In addition, to explore mediating factors, more reliable variables, prospectively acquired, should be included in multiple mediation analyses, such as physical activity, diet, and socioeconomic status. Supplementary Information Supplementary Material 1. Acknowledgements We would like to thank the National Natural Science Foundation of China and the Third Affiliated Hospital of Sun Yat-sen University. Abbreviations Assisted reproductive technology Body mass index Fasting plasma glucose Oral glucose tolerance test High-density lipoprotein cholesterol International association of the diabetes and pregnancy study groups Inverse probability weighting Gestational diabetes mellitus Low birth weight Low-density lipoprotein cholesterol Large for gestational age Small for gestational age Triglycerides Total cholesterol Authors’ contributions All the authors substantially contributed to the manuscript. HBL, ZYL, and LG were responsible for the conception and design of the study. ZX, HL, CX, and YL contributed to data collection and management. ZL, CX, and YL were responsible for analysing and interpreting the data. HBL and HL drafted the manuscript. ZYL and LG revised the manuscript. All the authors have read and approved the final manuscript. Funding This study was supported by the research grant “Development and evaluation of a precise intervention on physical inactivity to prevent gestational diabetes mellitus based on the ecological model” (Grant No. 72174216) from the National Natural Science Foundation of China. Data availability The data and materials that support the findings of this study are available from the corresponding author upon reasonable request. Declarations Competing interests The authors declare no competing interests. Ethics approval and consent to participate This study was approved by the Ethics Committee of Sun Yat-sen University School of Nursing (Grant No. L2022SYSU-HL-016) according to the principles of the Declaration of Helsiki. This was a retrospective study. The reported data were anonymized, and the requirement for informed consent was therefore waived. Consent for publication Not applicable. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Contributor Information Lingling Gao, Email: llgao@mpu.edu.mo, Email: gaoll@mail.sysu.edu.cn. Zhongyu Li, Email: lzhy1023@hotmail.com. References Associated Data Supplementary Materials Supplementary Material 1. Data Availability Statement The data and materials that support the findings of this study are available from the corresponding author upon reasonable request.